Russell Investments Group Ltd. Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Russell Investments Group Ltd. boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 88.9% in the third quarter, Holdings Channel.com reports. The institutional investor owned 1,101,847 shares of the pharmacy operator’s stock after acquiring an additional 518,679 shares during the period. Russell Investments Group Ltd.’s holdings in Walgreens Boots Alliance were worth $34,599,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. WFA of San Diego LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $32,000. Bank of New Hampshire grew its stake in shares of Walgreens Boots Alliance by 56.4% during the 3rd quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 346 shares during the period. Ronald Blue Trust Inc. bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at approximately $46,000. Baystate Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 209.4% during the 2nd quarter. Baystate Wealth Management LLC now owns 1,216 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 823 shares during the period. Finally, CX Institutional bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at approximately $47,000. Hedge funds and other institutional investors own 56.71% of the company’s stock.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $39.89, for a total value of $660,977.30. Following the sale, the director now owns 5,515 shares in the company, valued at $219,993.35. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $39.89, for a total value of $660,977.30. Following the completion of the sale, the director now directly owns 5,515 shares in the company, valued at $219,993.35. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Kevin M. Ban sold 10,303 shares of the stock in a transaction dated Friday, November 18th. The shares were sold at an average price of $40.19, for a total value of $414,077.57. Following the completion of the sale, the executive vice president now owns 27,916 shares of the company’s stock, valued at $1,121,944.04. The disclosure for this sale can be found here. 17.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on WBA shares. Evercore ISI cut their price objective on Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating for the company in a research note on Monday, October 3rd. Mizuho boosted their price objective on Walgreens Boots Alliance from $36.00 to $41.00 and gave the company a “neutral” rating in a research note on Wednesday, December 14th. Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $43.00 to $54.00 in a research note on Tuesday, November 22nd. StockNews.com downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Wednesday, October 5th. Finally, Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $43.00 to $54.00 in a research note on Tuesday, November 22nd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $43.46.

Walgreens Boots Alliance Stock Down 2.1 %

Shares of WBA opened at $35.90 on Wednesday. The stock has a market capitalization of $30.96 billion, a price-to-earnings ratio of -10.44, a price-to-earnings-growth ratio of 1.63 and a beta of 0.75. Walgreens Boots Alliance, Inc. has a 1 year low of $30.39 and a 1 year high of $51.87. The business’s 50 day simple moving average is $38.86 and its 200-day simple moving average is $37.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.70 and a quick ratio of 0.36.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.01. Walgreens Boots Alliance had a positive return on equity of 13.57% and a negative net margin of 2.24%. The company had revenue of $33.38 billion for the quarter, compared to analyst estimates of $33.04 billion. During the same quarter in the prior year, the firm posted $1.68 EPS. Walgreens Boots Alliance’s quarterly revenue was down 1.5% compared to the same quarter last year. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 12th. Investors of record on Tuesday, November 15th were issued a dividend of $0.48 per share. The ex-dividend date of this dividend was Monday, November 14th. This represents a $1.92 annualized dividend and a yield of 5.35%. Walgreens Boots Alliance’s payout ratio is presently -55.81%.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.